For: | Hou YY, Zhou Y, Lu SH, Qi WD, Xu C, Hou J, Tan YS. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol 2009; 15(15): 1910-1913 [PMID: 19370794 DOI: 10.3748/wjg.15.1910] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i15/1910.htm |
Number | Citing Articles |
1 |
Yoshiya Fujimoto, Takashi Akiyoshi, Tsuyoshi Konishi, Satoshi Nagayama, Yosuke Fukunaga, Masashi Ueno. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. International Journal of Colorectal Disease 2014; 29(1): 111 doi: 10.1007/s00384-013-1769-7
|
2 |
Ryo Takahashi, Satoshi Nagayama, Yukiko Mori, Hiroyoshi Isoda, Akihiko Yoshizawa, Toshiaki Manabe, Yoshiharu Sakai. A large cystic gastrointestinal stromal tumor of the rectum in the retrorectal space. International Journal of Clinical Oncology 2010; 15(6): 601 doi: 10.1007/s10147-010-0084-3
|
3 |
Burton L. Eisenberg, Jonathan C. Trent. Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors. International Journal of Cancer 2011; 129(11): 2533 doi: 10.1002/ijc.26234
|
4 |
David Reynoso, Jonathan C Trent. Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments. Current Opinion in Oncology 2010; 22(4): 330 doi: 10.1097/CCO.0b013e32833aaaad
|
5 |
Carla Rameri Alexandre Silva de Azevedo, Tadeu Ferreira Paiva, Benedito Mauro Rossi, Gustavo Cardoso Guimarães, Maria Dirlei Ferreira de Souza Begnami, Thiago Bueno Oliveira, Milton José Barros e Silva, Marcello Ferretti Fanelli, Celso Abdon Lopes de Mello. Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST. International Journal of Clinical Oncology 2011; 16(3): 279 doi: 10.1007/s10147-010-0133-y
|
6 |
H. Rejab, W. Ben Kridis, H. Ben Ameur, J. Feki, M. Frikha, M. Issam Beyrouti. Tumeur stromale rectale : à propos d’une observation. Pathologie Biologie 2013; 61(3): 134 doi: 10.1016/j.patbio.2013.03.006
|
7 |
Mariem Ben Rekaya, Feryel Ksontini, Linda Bel Haj Kacem, Farah Sassi, Emna Harigua‐Souiai, Ryma Boujneh, Ahmed H'mayada, Yosra Zaimi, Mouna Ayadi, Mediha Trabelsi, Ridha Mrad, Soumaya Rammeh. Pathologic complete response to neoadjuvant imatinib of a gastric stromal tumor with concomitant mutations in KIT: A case report and literature review. Clinical Case Reports 2023; 11(6) doi: 10.1002/ccr3.7463
|
8 |
Manabu Kaneko, Shigenobu Emoto, Koji Murono, Hirofumi Sonoda, Masaya Hiyoshi, Kazuhito Sasaki, Yasutaka Shuno, Takeshi Nishikawa, Toshiaki Tanaka, Keisuke Hata, Kazushige Kawai, Hiroaki Nozawa. Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors. Surgery Today 2019; 49(6): 460 doi: 10.1007/s00595-018-1737-5
|
9 |
Jenia Jenab-Wolcott, Bruce Giantonio. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 141 doi: 10.1007/978-1-4614-6015-2_9
|
10 |
Nalini Raju, Reetesh Pai, Mark Lane Welton. Colorectal Surgery. 2013; : 326 doi: 10.1016/B978-1-4377-1724-2.00020-9
|
11 |
Paulo Rocha França Neto, Leandro Alves Gomes Ramos, Luciana Costa Silva, Cristiane Koizimi M Fernandes, Antônio Lacerda-Filho. Uso neoadjuvante do mesilato de imatinibe no tratamento de GIST retal volumoso: relato de caso. Revista Brasileira de Coloproctologia 2011; 31(1): 89 doi: 10.1590/S0101-98802011000100014
|
12 |
Tingting Wu, Xiaobin Cheng, Wenbin Chen. Complete response of advanced rectal gastrointestinal stromal tumors after imatinib treatment: A case report and literature review. Medicine 2022; 101(32): e29411 doi: 10.1097/MD.0000000000029411
|